Skip to main content
. 2018 Jan 2;19(1):121. doi: 10.3390/ijms19010121
A immunocompetent Acanthamoeba sp.-infected mice
AK Acanthamoeba keratitis
AM arithmetic mean
AM 22 amoebic strain no. 22
Med medians
AML acute myeloid leukemia
AS immunosuppressed Acanthamoeba sp.-infected mice
C immunocompetent uninfected control group mice
CA cutaneous acanthamoebiasis
cAMP cyclic adenosine monophosphate
COX-1 cyclooxygenase-1
COX-2 cyclooxygenase-2
CS immunosuppressed uninfected mice
dpi days post infection
ERK 1/2 extracellular signal-regulated kinase
PGA prostaglandin
PGE2 prostaglandin E2
GAE granulomatous amebic encephalitis
IK immunocompetent
IL-4 interkeukin 4
IL-13 Interleukin 13
IL-β interleukin 1 beta
iNOS inducible nitric oxide synthase
IS immunosuppressed
JNK c-Jun N-terminal kinases
K-W test Kruskal-Wallis test
LI relative weight ratio of lungs
LPS lipopolysaccharide
MPS methylprednisolone sodium succinate
MRP4 multidrug resistance protein 4
NF-κB nuclear transcription factor
NSAIDs non-steroidal anti-inflammatory drugs
p38 mitogen-activated protein kinase
rs correlation coefficient
SD standard deviation
TLR2 Toll-like receptor 2
TLR4 Toll-like receptor 4
TXs thromboxanes
TXA2 thromboxane A2
TXB2 thromboxane B2